Sciphage is a revolutionary brand that specializes in phage technology for the control of bacterial infections in human and animal health, as well as in contaminated environments. As a spin-off of the University of Andes, Colombia, Sciphage follows a Business to Business model. The company generates revenue by directly selling their innovative SalmoFree® phage product to companies in the poultry industry.

By incorporating this natural alternative to antibiotics in animal nutrition, Sciphage enhances the health of broilers by modulating beneficial bacteria in microbiota and reducing the presence of pathogens such as Salmonella. With a focus on environmental sustainability, Sciphage eliminates the indiscriminate use of antibiotics, positively impacting various sectors of the economy. The brand's comprehensive service includes a farm diagnostic algorithm that provides valuable insights for farmers.

The expertise of Martha Vives, a renowned Microbiologist PhD, and her multidisciplinary team, ensures the effectiveness and quality of Sciphage's phage technology. Led by CEO Viviana Clavijo and CTO Angela Holguin, the dedicated team at Sciphage is committed to innovation, collaboration, and the development of safe and affordable solutions for bacterial control in agriculture and healthcare